Fulcrum Therapeutics
Unlocking gene control mechanisms to develop small molecule therapies
3
Funding Rounds
$203.5m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Ka** Ha****** | - | - | |
| Ka**** Do**** | - | - | - |
| Al** Ez******* | - | - | - |
| Ja*** Co***** (e************ | - | - | - |
| Ro**** Go*** | - | - | - |
| Br*** St**** | - | - | |
| So*** L. Ba*** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Fulcrum Therapeutics has raised a total of $135m in funding over 3 rounds.
Key Insights:
- Fulcrum Therapeutics Series B round, September 2018: $80m
- Fulcrum Therapeutics Series A round, July 2016: $55m
- Fulcrum Therapeutics, Inc. funding round, June 2020: $68.5m
Fulcrum Therapeutics Series B round, September 2018
$80m
Fulcrum Therapeutics Series A round, July 2016
$55m
Fulcrum Therapeutics, Inc. funding round, June 2020
$68.5m
Industries
Fulcrum Therapeutics is active in the following industries:
- Biotechnology
- Biomedical engineering
- Engineering
- Synthetic chemistry
- Biology
- Technology